Phase I/II trial of a peptide-based COVID-19 T-cell activator in patients with B-cell deficiencyNATURE COMMUNICATIONSIF15.72023-08-1812OAAI
Biomarker-driven therapies for metastatic uveal melanoma: A prospective precision oncology feasibility studyEUROPEAN JOURNAL OF CANCERIF7.12022-07-014PRE
90-yttrium-ibritumomab tiuxetan as first-line treatment for follicular lymphoma: updated efficacy and safety results at an extended median follow-up of 9.6 yearsANNALS OF HEMATOLOGYIF2.42022-02-1212OAAI
Original Research Treatment with ribociclib shows favourable immunomodulatory effects in patients with hormone receptor-positive breast cancer-findings from the RIBECCA trialEUROPEAN JOURNAL OF CANCERIF7.12022-02-0116OAAI
Investigation of spleen CXCR4 expression by [68Ga]Pentixafor PET in a cohort of 145 solid cancer patientsEJNMMI RESEARCHIF32021-08-2119OAAI
High-affinity T-cell receptor specific for MyD88 L265P mutation for adoptive T-cell therapy of B-cell malignanciesJOURNAL FOR IMMUNOTHERAPY OF CANCERIF10.62021-07-309OAAI
Treatment of metastatic uveal melanoma (mUM) through genomic profilingANNALS OF ONCOLOGYIF65.42020-09-011OAAI